Treatment of Atopic Dermatitis with Tralokinumab, an Anti-IL-13 Monoclonal Antibody.

Andreas Wollenberg,Michael D Howell,Emma Guttman-Yassky,Jonathan I Silverberg,Christopher Kell,Koustubh Ranade,Rachel Moate,René van der Merwe

Journal of Allergy and Clinical Immunology（2019）

引用 300|浏览13

暂无评分

摘要

Tralokinumab treatment was associated with early and sustained improvements in AD symptoms, and an acceptable safety and tolerability profile, thereby providing evidence for targeting IL-13 in AD.

查看译文

关键词

Atopic dermatitis,tralokinumab,eczema,IL-13

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要